Results 21 to 30 of about 562 (139)

Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives. [PDF]

Exp Dermatol
ABSTRACT JAK inhibitors are used to treat various inflammatory skin diseases. However, systemic formulations are associated with an increased risk of major adverse events. Ruxolitinib 1.5% cream is a selective topical JAK1 and JAK2 inhibitor, which has recently been approved by EMA and MHRA for treating non‐segmental vitiligo, while being FDA‐approved ...
Spadafora M, Morsia S, Di Lernia VG, Kaleci S, Pellacani G, Longo C.   +5 more
europepmc   +2 more sources

Look Outside the Brain: Incidentally Detected Cutis Verticis Gyrata. [PDF]

Clin Case Rep
ABSTRACT Cutis verticis gyrata (CVG) is a rare dermatological condition characterized by thickened and folded scalp skin, often discovered incidentally during neuroimaging for unrelated issues. Clinicians should remain vigilant and consider a multidisciplinary approach to recognize and manage potential comorbidities, emphasizing the importance of a ...
Devkota S, Bhatta OP.
europepmc   +2 more sources

Scleromyxedema [PDF]

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2020
SummaryScleromyxedema is a rare, cutaneous deposition disorder from the group of mucinoses, which can affect multiple organs and is virtually always associated with a monoclonal gammopathy. Cutaneous manifestations are usually generalized, 2 to 3 mm sized, dome‐shaped or flat‐topped, waxy, slightly red to skin‐colored papules and sclerodermoid ...
Jochen H O, Hoffmann, Alexander H, Enk
openaire   +4 more sources

Discrete papular lichen myxedematosus successfully treated with isotretinoin [PDF]

JAAD Case Reports
Alexa Figueroa Baiges, BS, Nina Punyamurthy, MD, Alexander M. Maley, MD   +2 more
doaj   +2 more sources

Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin [PDF]

JAAD Case Reports, 2023
Donglin Zhang, BA, Kimberly Sable, MD, Allison Miller, MD, Molly Hinshaw, MD, Timothy Schmidt, MD, Bridget E. Shields, MD   +5 more
doaj   +2 more sources

An unusual case of granulomatous scleromyxedema

JAAD Case Reports, 2022
Sara Sabeti, Katerina Yale
exaly   +3 more sources

Scleromyxedema: clinical diagnosis and autopsy findings [PDF]

Anais Brasileiros de Dermatologia, 2016
Scleromyxedema is a rare chronic cutaneous mucinosis of unknown etiology. It is characterized by papular eruption and scleroderma with microscopic evidence of mucin deposition, fibroblast proliferation, and fibrosis.
Ana Carolina Bulhões Sala, Paulo Rowilson Cunha, Clóvis Antônio Lopes Pinto, Célia Antônia Xavier de Moraes Alves, Ingrid Barreto Paiva, Ana Paula Vieira Araujo   +5 more
doaj   +1 more source

Successful treatment of scleromyxedema with dupilumab: A case report [PDF]

JAAD Case Reports
Abdulelah Alghamdi, MBBS, Abdulrahman Alfawzan, MBBS, Khalid Aburas, MBBS, Nedhal Ayoub, MD, Mohammad Almohideb, MD   +4 more
doaj   +2 more sources

Scleromyxedema

Internal Medicine, 2014
To synthesize the current known data on pathogenesis and treatment of scleromyxedema. This review will also highlight the clinical presentation, systemic features and outcomes and distinguishing features between scleromyxedema and scleroderma, as a common mimic.Most recent publications have focused on describing treatment responses with novel therapies,
Bogner, Ryan R., Wetter, David A., Dingli, David   +2 more
openaire   +5 more sources

Paraneoplastic atypical scleromyxedema with advanced gastric cancer

JAAD Case Reports, 2017
Se Jin Oh, Jong Hee Lee, Seung Hwan Oh
exaly   +3 more sources